Baxano Surgical Inc (BAXS) 0.02 $BAXS
Most active Nasdaq-traded stocks
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
BAXS: 0.02 (unch), GILD: 104.13 (-0.18), PLUG: 2.93 (-0.17), GERN: 3.24 (+0.01), ARCP: 8.99 (-0.24), MSFT: 46.95 (-0.22), AAPL: 109.73 (-1.89), CSCO: 26.85 (-0.14)
Not much of Baxano left
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:28AM CST
BAXS: 0.02 (unch)
Baxano Surgical to sell its surgical products through Voluntary Chapter 11 Court Supervised Auction Process under Section 363 of the Bankruptcy Code
M2 - Fri Nov 14, 6:59AM CST
Medical device company Baxano Surgical (NasdaqGM:BAXS) said on Thursday that it has filed a voluntary petition for relief under Chapter 11 of the US Bankruptcy Code in the US Bankruptcy Court for the District of Delaware to facilitate the sale of its minimally invasive products under Section 363 of the Bankruptcy Code.
BAXS: 0.02 (unch), HTGC: 14.44 (-0.42)
Baxano Surgical, Inc. Announces Termination of Its Nasdaq Listing
GlobeNewswire - Thu Nov 13, 4:45PM CST
Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it is terminating its listing on The Nasdaq Global Market as of the close of business on November 24, 2014. The company has previously received notices from Nasdaq that it has failed to maintain a minimum bid price of $1.00 per share. In light of its current financial condition, the company does not anticipate that it will be able to meet such minimums or continue to meet other Nasdaq listing standards in the future. In addition, the company has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in order to facilitate a going concern sale of the company. Following the termination of its listing on Nasdaq, the company intends to terminate its public reporting obligations under the Exchange Act as soon as possible.
BAXS: 0.02 (unch)
Baxano off big premarket on bankruptcy filing
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 8:31AM CST
BAXS: 0.02 (unch)
Baxano Surgical to Sell Product Lines Through Voluntary Chapter 11 Court Supervised Auction Process
GlobeNewswire - Thu Nov 13, 6:30AM CST
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. The bankruptcy filing was effected in order to facilitate a going concern sale of the Baxano Surgical minimally invasive products under Section 363 of the Bankruptcy Code.
BAXS: 0.02 (unch)
Executive transitions at Baxano
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 12:21PM CST
BAXS: 0.02 (unch)
Technical Updates on Health Care Supplies Sector Stocks - Align Technology, DENTSPLY Intl., Baxano Surgical, Cerus, and Alere
PR Newswire - Wed Nov 05, 7:55AM CST
Investor-Edge has initiated coverage on the following equities: Align Technology Inc. (NASDAQ: ALGN), DENTSPLY International Inc. (NASDAQ: XRAY), Baxano Surgical Inc. (NASDAQ: BAXS), Cerus Corporation (NASDAQ: CERS), and Alere Inc. (NYSE: ALR). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, November 04, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,383.84, up 0.10% and the NASDAQ Composite closed at 4,623.64, down 0.33%. The S&P 500 finished the session 0.28% lower at 2,012.10. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 779.72, up 0.09%, with the index gaining 10.19% in the previous three months. Register for your complimentary reports on these five stocks at:
CERS: 4.87 (+0.27), BAXS: 0.02 (unch), ALGN: 55.73 (-0.73), ALR: 36.32 (-0.67), XRAY: 54.21 (-0.24)
JH Technologies Hosts North California Society for Microscopy Meeting
PRWeb - Wed Oct 29, 10:01AM CDT
JH Technologies hosted the Northern California Society for Microscopy meeting in it's training center located in Fremont California. The Microscopy Society of America (MSA) is a non-profit organization dedicated to the promotion and advancement of techniques and applications of microscopy and microanalysis in all relevant scientific disciplines. The fall Northern California Local Affiliated Society was fortunate to have Professor Michael Isaacson, UC Santa Cruz Department of Electrical Engineering, discuss a brief history of the utilization of microscopic tools for exploring inner space at the atomic and nanoscale dimensions, and discuss new advances in instrumentation that allow for both the visualization and spectroscopic analysis at such scales.
BAXS: 0.02 (unch)
5 Stocks Under $10 Set to Soar
at The Street - Fri Oct 24, 1:39PM CDT
These under-$10 stocks look ready to trade higher from current levels.
BAXS: 0.02 (unch), FOMX: 6.42 (+0.19), ARCO: 5.95 (-0.14), SNSS: 2.26 (unch), SZMK: 6.29 (-0.15)
Baxano Surgical Completes Financing and Continues Streamlined Business Operations
GlobeNewswire - Thu Sep 25, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, announced that the Company has completed a recent subordinated convertible note financing of approximately $1.5 million to extend its cash runway. In connection with the financing, the Company has also streamlined its business to reduce its operating expenses while maintaining its commercial operations.
BAXS: 0.02 (unch)
Baxano Surgical to Explore Strategic Alternatives for Its MIS Spine Business
GlobeNewswire - Thu Sep 18, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company has engaged Houlihan Lokey as its financial advisor to advise it on potential strategic alternatives for the Company's business.
BAXS: 0.02 (unch)
Baxano Surgical to Train 35 Surgeons on Advanced MIS Techniques
GlobeNewswire - Fri Sep 12, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company is participating in an MIS-based training course hosted by the International Society for the Advancement of Spine Surgery (ISASS), and co-chaired by Anthony Yeung, MD and James J Yue, MD.
BAXS: 0.02 (unch)
Baxano Surgical, Inc. Reports Operating Results for the Second Quarter of 2014, Issues Third Quarter 2014 Guidance
GlobeNewswire - Tue Aug 05, 3:08PM CDT
- Second quarter revenue of $4.7 million, representing year-over-year growth of 20.1% and sequential growth of 5.5% -
BAXS: 0.02 (unch)
Baxano Surgical, Inc. Announces Two New Patents for VEO Direct Lateral and AxiaLIF Minimally Invasive Interbody Fusion Systems
GlobeNewswire - Tue Aug 05, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the United States Patent and Trademark Office has issued two patents on key Baxano Surgical technologies, bringing the company's patent portfolio to 92 patents in the U.S.
BAXS: 0.02 (unch)
Baxano Surgical Announces Second Quarter 2014 Earnings Conference Call and Webcast
GlobeNewswire - Thu Jul 24, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that it will release second quarter 2014 financial results on Tuesday, August 5, 2014 after the market closes. Ken Reali, President and Chief Executive Officer and Tim Shannon, Chief Financial Officer, will then conduct a conference call at 4:30 pm ET to review the results.
BAXS: 0.02 (unch)
Economic Analysis of Minimally Invasive Spine Fusion Using AxiaLIF Accepted for Publication in the Journal of Managed Care Medicine
GlobeNewswire - Fri Jul 18, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Journal of Managed Care Medicine, a peer-reviewed national publication, has accepted an economic analysis of the AxiaLIF pre-sacral interbody fusion procedure in comparison to transforaminal lumbar interbody fusion (TLIF).
BAXS: 0.02 (unch)
Baxano Surgical Announces First Clinical Use of the Avance MIS Pedicle Screw System
GlobeNewswire - Mon Jun 30, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the first case utilizing the Avance(TM) MIS Pedicle Screw System was recently performed by Dr. Sameer Mathur in Cary, NC. The innovative design of Avance provides for an easy-to-use, percutaneous pedicle screw system that addresses single, complex and multi-level spinal pathologies with minimal tissue disruption and trauma. The Avance system will be in limited market release through the end of third quarter of 2014 and is planned for full launch in the fourth quarter of 2014.
BAXS: 0.02 (unch)
Most active Nasdaq-traded stocks
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
BAXS: 0.02 (unch), GILD: 104.13 (-0.18), PLUG: 2.93 (-0.17), GERN: 3.24 (+0.01), ARCP: 8.99 (-0.24), MSFT: 46.95 (-0.22), AAPL: 109.73 (-1.89), CSCO: 26.85 (-0.14)
Not much of Baxano left
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:28AM CST
BAXS: 0.02 (unch)
Baxano Surgical to sell its surgical products through Voluntary Chapter 11 Court Supervised Auction Process under Section 363 of the Bankruptcy Code
M2 - Fri Nov 14, 6:59AM CST
Medical device company Baxano Surgical (NasdaqGM:BAXS) said on Thursday that it has filed a voluntary petition for relief under Chapter 11 of the US Bankruptcy Code in the US Bankruptcy Court for the District of Delaware to facilitate the sale of its minimally invasive products under Section 363 of the Bankruptcy Code.
BAXS: 0.02 (unch), HTGC: 14.44 (-0.42)
Baxano Surgical, Inc. Announces Termination of Its Nasdaq Listing
GlobeNewswire - Thu Nov 13, 4:45PM CST
Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it is terminating its listing on The Nasdaq Global Market as of the close of business on November 24, 2014. The company has previously received notices from Nasdaq that it has failed to maintain a minimum bid price of $1.00 per share. In light of its current financial condition, the company does not anticipate that it will be able to meet such minimums or continue to meet other Nasdaq listing standards in the future. In addition, the company has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in order to facilitate a going concern sale of the company. Following the termination of its listing on Nasdaq, the company intends to terminate its public reporting obligations under the Exchange Act as soon as possible.
BAXS: 0.02 (unch)
Baxano off big premarket on bankruptcy filing
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 8:31AM CST
BAXS: 0.02 (unch)
Baxano Surgical to Sell Product Lines Through Voluntary Chapter 11 Court Supervised Auction Process
GlobeNewswire - Thu Nov 13, 6:30AM CST
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. The bankruptcy filing was effected in order to facilitate a going concern sale of the Baxano Surgical minimally invasive products under Section 363 of the Bankruptcy Code.
BAXS: 0.02 (unch)
Executive transitions at Baxano
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 12:21PM CST
BAXS: 0.02 (unch)
Technical Updates on Health Care Supplies Sector Stocks - Align Technology, DENTSPLY Intl., Baxano Surgical, Cerus, and Alere
PR Newswire - Wed Nov 05, 7:55AM CST
Investor-Edge has initiated coverage on the following equities: Align Technology Inc. (NASDAQ: ALGN), DENTSPLY International Inc. (NASDAQ: XRAY), Baxano Surgical Inc. (NASDAQ: BAXS), Cerus Corporation (NASDAQ: CERS), and Alere Inc. (NYSE: ALR). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, November 04, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,383.84, up 0.10% and the NASDAQ Composite closed at 4,623.64, down 0.33%. The S&P 500 finished the session 0.28% lower at 2,012.10. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 779.72, up 0.09%, with the index gaining 10.19% in the previous three months. Register for your complimentary reports on these five stocks at:
CERS: 4.87 (+0.27), BAXS: 0.02 (unch), ALGN: 55.73 (-0.73), ALR: 36.32 (-0.67), XRAY: 54.21 (-0.24)
JH Technologies Hosts North California Society for Microscopy Meeting
PRWeb - Wed Oct 29, 10:01AM CDT
JH Technologies hosted the Northern California Society for Microscopy meeting in it's training center located in Fremont California. The Microscopy Society of America (MSA) is a non-profit organization dedicated to the promotion and advancement of techniques and applications of microscopy and microanalysis in all relevant scientific disciplines. The fall Northern California Local Affiliated Society was fortunate to have Professor Michael Isaacson, UC Santa Cruz Department of Electrical Engineering, discuss a brief history of the utilization of microscopic tools for exploring inner space at the atomic and nanoscale dimensions, and discuss new advances in instrumentation that allow for both the visualization and spectroscopic analysis at such scales.
BAXS: 0.02 (unch)
5 Stocks Under $10 Set to Soar
at The Street - Fri Oct 24, 1:39PM CDT
These under-$10 stocks look ready to trade higher from current levels.
BAXS: 0.02 (unch), FOMX: 6.42 (+0.19), ARCO: 5.95 (-0.14), SNSS: 2.26 (unch), SZMK: 6.29 (-0.15)
Baxano Surgical Completes Financing and Continues Streamlined Business Operations
GlobeNewswire - Thu Sep 25, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, announced that the Company has completed a recent subordinated convertible note financing of approximately $1.5 million to extend its cash runway. In connection with the financing, the Company has also streamlined its business to reduce its operating expenses while maintaining its commercial operations.
BAXS: 0.02 (unch)
Baxano Surgical to Explore Strategic Alternatives for Its MIS Spine Business
GlobeNewswire - Thu Sep 18, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company has engaged Houlihan Lokey as its financial advisor to advise it on potential strategic alternatives for the Company's business.
BAXS: 0.02 (unch)
Baxano Surgical to Train 35 Surgeons on Advanced MIS Techniques
GlobeNewswire - Fri Sep 12, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company is participating in an MIS-based training course hosted by the International Society for the Advancement of Spine Surgery (ISASS), and co-chaired by Anthony Yeung, MD and James J Yue, MD.
BAXS: 0.02 (unch)
Baxano Surgical, Inc. Reports Operating Results for the Second Quarter of 2014, Issues Third Quarter 2014 Guidance
GlobeNewswire - Tue Aug 05, 3:08PM CDT
- Second quarter revenue of $4.7 million, representing year-over-year growth of 20.1% and sequential growth of 5.5% -
BAXS: 0.02 (unch)
Baxano Surgical, Inc. Announces Two New Patents for VEO Direct Lateral and AxiaLIF Minimally Invasive Interbody Fusion Systems
GlobeNewswire - Tue Aug 05, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the United States Patent and Trademark Office has issued two patents on key Baxano Surgical technologies, bringing the company's patent portfolio to 92 patents in the U.S.
BAXS: 0.02 (unch)
Baxano Surgical Announces Second Quarter 2014 Earnings Conference Call and Webcast
GlobeNewswire - Thu Jul 24, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that it will release second quarter 2014 financial results on Tuesday, August 5, 2014 after the market closes. Ken Reali, President and Chief Executive Officer and Tim Shannon, Chief Financial Officer, will then conduct a conference call at 4:30 pm ET to review the results.
BAXS: 0.02 (unch)
Economic Analysis of Minimally Invasive Spine Fusion Using AxiaLIF Accepted for Publication in the Journal of Managed Care Medicine
GlobeNewswire - Fri Jul 18, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Journal of Managed Care Medicine, a peer-reviewed national publication, has accepted an economic analysis of the AxiaLIF pre-sacral interbody fusion procedure in comparison to transforaminal lumbar interbody fusion (TLIF).
BAXS: 0.02 (unch)
Baxano Surgical Announces First Clinical Use of the Avance MIS Pedicle Screw System
GlobeNewswire - Mon Jun 30, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the first case utilizing the Avance(TM) MIS Pedicle Screw System was recently performed by Dr. Sameer Mathur in Cary, NC. The innovative design of Avance provides for an easy-to-use, percutaneous pedicle screw system that addresses single, complex and multi-level spinal pathologies with minimal tissue disruption and trauma. The Avance system will be in limited market release through the end of third quarter of 2014 and is planned for full launch in the fourth quarter of 2014.
BAXS: 0.02 (unch)
